ROCK2 and cerebral cavernous malformation: Pharmacological studies further show that ROCK inhibition by fasudil, atorvastatin, and a newly identified ROCK2 specific inhibitor limits CCM-like lesion formation in multiple mouse models of CCM [104,105,106], highlighting ROCK inhibition may be a valid therapy for CCM disease.